In this edition, we look at non-pharmacotherapeutic options for rheumatoid arthritis, the pausing of eight CAR T-cell trials and more.
Read the full coverage here:
Speaker: SetPoint System responses continue to improve 'over time' in rheumatoid arthritis
Three deaths halt Novartis CAR T-cell trials in autoimmune diseases
Nearly 60% of US adults with arthritis report moderate to severe joint pain
Calabrese: GLP-1s may act directly as anti-inflammatories 'even without obesity'
'Where is the tissue damage?' Data suggest fibromyalgia a central nervous system disorder
14 Sept 2026
Trending Orthopedic News from August 2026
Welcome to the "Healio Minute" podcast. This is a look at some of the trending headlines in the field of Orthopedics.
I'm your host, Erin Welsh. In this edition, we look at the dismissal of patient priorities, infection prevention in TKA, and more.
8 Sept 2026
Trending Rheumatology News from August 2026
In this edition, we look at the pathogenesis of rheumatoid arthritis, immune-mediated inflammatory diseases and more.
Read the full coverage here:
'We were surprised': Study reveals molecular basis for rheumatoid arthritis pathogenesis
'Difficult-to-treat' immune-mediated inflammatory diseases call for holistic strategy
Opioid use disorder 'relatively common' in patients with rheumatic diseases
'We need more options': Novel nerve stimulation approach improves fibromyalgia pain
'Chamomile is God's Xanax': Integrative medicine gives patients more options
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
3 ratings
Podcast Authority Score: 43 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
61
Social presence
0
YouTube
0
Engagement
60
Host of Healio Minute?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
